Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
Differential blood test: Uses, procedure, and results
The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications, Molecular Cancer
Scientists unravel tumor neutrophil complexity, discover therapeutic subset
Genetic signature may predict response to immunotherapy for non-small cell lung cancer - ecancer
Frontiers Targeting Neutrophils for Promoting the Resolution of Inflammation
Molecules, Free Full-Text
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of ALK rearranged lung cancer treatment - ecancer
White Blood Cells - Granulocytes - Agranulocytes - TeachMePhysiology
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit - ecancer
The Neutrophil - ScienceDirect
Multiple Myeloma - Physiopedia
WCLC 2023: Benmelstobart plus anlotinib and chemotherapy shows benefit for patients with extensive-stage small-cell lung cancer - ecancer
Heterogeneity of neutrophils in cancer: one size does not fit all
Clinical Translation of Neutrophil Imaging and Its Role in Cancer